Castle Biosciences, Inc.
CSTL
$24.06
$0.502.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.25% | 15.02% | 20.58% | 21.78% | 15.16% |
| Total Receivables | 15.92% | 33.38% | 33.72% | 35.83% | 46.86% |
| Inventory | 4.41% | -10.41% | 2.43% | 13.92% | 30.91% |
| Prepaid Expenses | 64.70% | 67.74% | 21.92% | 14.89% | 9.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.82% | 18.13% | 21.82% | 23.30% | 19.09% |
|
|
|||||
| Total Current Assets | 8.82% | 18.13% | 21.82% | 23.30% | 19.09% |
| Net Property, Plant & Equipment | 78.20% | 48.42% | 66.16% | 66.11% | 56.81% |
| Long-term Investments | 0.01% | 0.00% | 0.00% | 0.00% | -0.08% |
| Goodwill | 0.01% | 0.00% | 0.00% | 0.00% | -0.08% |
| Total Other Intangibles | -8.53% | -35.62% | -10.41% | -8.30% | -8.12% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -37.68% | -18.37% | -18.43% | 1.14% | 57.55% |
| Total Assets | 11.78% | 9.42% | 17.18% | 18.01% | 14.55% |
|
|
|||||
| Total Accounts Payable | 38.17% | -8.76% | -32.79% | -1.72% | 33.71% |
| Total Accrued Expenses | 12.26% | 14.93% | 9.77% | 26.05% | 14.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 186.70% | 114.13% | 69.21% | 59.95% | -37.64% |
| Total Finance Division Other Current Liabilities | 220.63% | 220.10% | 86.86% | 39.74% | 113.17% |
| Total Other Current Liabilities | 220.63% | 220.10% | 86.86% | 39.74% | 113.17% |
| Total Current Liabilities | 28.99% | 16.63% | 3.62% | 21.94% | 17.02% |
|
|
|||||
| Total Current Liabilities | 28.99% | 16.63% | 3.62% | 21.94% | 17.02% |
| Long-Term Debt | -19.10% | -10.79% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 84.43% | 3.58% | 3.23% | 11.20% | 11.89% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 306.31% | 680.10% | 856.92% | -- |
| Total Liabilities | 40.89% | 9.57% | 21.47% | 46.33% | 36.00% |
|
|
|||||
| Common Stock & APIC | 6.40% | 6.84% | 7.58% | 8.09% | 8.21% |
| Retained Earnings | -4.47% | -2.29% | 8.36% | 2.82% | -1.48% |
| Treasury Stock & Other | 122.67% | 218.02% | 69.12% | 766.20% | -19.44% |
| Total Common Equity | 7.43% | 9.40% | 16.50% | 14.33% | 11.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.43% | 9.40% | 16.50% | 14.33% | 11.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.43% | 9.40% | 16.50% | 14.33% | 11.91% |
|
|
|||||